NCT01251471View on ClinicalTrials.gov

Neural, Genetic, and Peripheral Correlates of SSRI Pharmaco-Response

PHASE4CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

July 31, 2014

Study Completion Date

March 31, 2015

Conditions
Depression
Interventions
DRUG

Escitalopram

10 mg/d; optional 20 mg/d after 2 weeks.

Trial Locations (1)

1090

Medical University of Vienna, Dept. of Psychiatry and Psychotherapy, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT01251471 - Neural, Genetic, and Peripheral Correlates of SSRI Pharmaco-Response | Biotech Hunter | Biotech Hunter